Stepan Q1 2024 Adj EPS $0.64 Beats $0.35 Estimate, Sales $551.418M Miss $575.825M Estimate

4/30/24 7:03:39 AM ET

Package Goods/Cosmetics

Consumer Discretionary

Get the next $SCL alert in real time by email

Stepan (NYSE:SCL) reported quarterly Adj earnings of $0.64 per share which beat the analyst consensus estimate of $0.35 by 82.86 percent. This is a 9.86 percent decrease over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $551.418 million which missed the analyst consensus estimate of $575.825 million by 4.24 percent. This is a 15.35 percent decrease over sales of $651.436 million the same period last year.

Get the next $SCL alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SCL

Date	Price Target	Rating	Analyst
10/19/2023	$89.00	Neutral → Buy	CL King
3/11/2022	$9.00 → $8.00	Outperform	RBC Capital
12/20/2021	$8.50 → $9.00	Outperform	RBC Capital

More analyst ratings

$SCL
Press Releases

Fastest customizable press release news feed in the world

Stepan Increases Quarterly Cash Dividend, Marking the 57th Consecutive Year of Increases
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.7%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.385 per share is payable on December 13, 2024, to common stockholders of record on November 29, 2024. The increase marks the 57th consecutive year in which the quarterly dividend on the Company's common stock has increased. Corporate Profile Stepan Company is a major manufacturer of specialty and intermediate chemic
10/30/24 7:00:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary
Stepan Reports Third Quarter 2024 Results
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Third Quarter 2024 Highlights Reported net income was $23.6 million, up 88% versus prior year. Adjusted net income(1) was $23.7 million, up 61% versus prior year, largely due to higher margins and a lower effective tax rate. The year-over-year change in effective tax rate positively impacted net income by $6.8 million, or $0.30 per diluted share.EBITDA(2) was $53.0 million and Adjusted EBITDA(2) was $53.1 million, up 18% and 11% respectively, year-over-year.Global sales volume was down 1%
10/30/24 7:00:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary
Stepan Promotes Luis E. Rojo to President and Chief Executive Officer
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,
10/30/24 6:55:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary

Stepan Promotes Luis E. Rojo to President and Chief Executive Officer
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,
10/30/24 6:55:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary
Stepan Company Announces Appointment of New Director
NORTHBROOK, Ill., Feb. 15, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Susan M. Lewis as a Director of Stepan, effective on February 15, 2024. Ms. Lewis spent over 30 years at Dow Inc., a materials science company, and was part of the management team of Corteva, Inc., a global agriculture company, following its spinoff from DowDuPont Inc. Ms. Lewis served as Senior Vice President, Global Operations of Corteva from 2018 until her retirement in 2021, after which she worked as a business and executive consultant through 2023. Ms. Lewis held senior management roles with operations, sustainability and risk management responsibilities and led organizational r
2/15/24 4:30:00 PM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary
AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors
VALENCIA, Calif. and MELBOURNE, Australia, June 01, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH))) ("AVITA Medical"), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today the appointment of James Corbett and Jan Stern Reed to its Board of Directors effective July 1, 2021. Mr. Corbett has approximately 40 years of leadership experience in the medical device field, most recently, as CEO of CathWorks Ltd., a software-based medical technology company. Mr. Corbett has extensive global commercial and operating experience, serving as an
6/1/21 4:01:00 PM ET
$SCL
$RCEL
$ANGO
Package Goods/Cosmetics
Consumer Discretionary
Medical/Dental Instruments
Health Care

$SCL
Financials

Live finance-specific insights

Stepan Increases Quarterly Cash Dividend, Marking the 57th Consecutive Year of Increases
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.7%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.385 per share is payable on December 13, 2024, to common stockholders of record on November 29, 2024. The increase marks the 57th consecutive year in which the quarterly dividend on the Company's common stock has increased. Corporate Profile Stepan Company is a major manufacturer of specialty and intermediate chemic
10/30/24 7:00:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary
Stepan Reports Third Quarter 2024 Results
NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Third Quarter 2024 Highlights Reported net income was $23.6 million, up 88% versus prior year. Adjusted net income(1) was $23.7 million, up 61% versus prior year, largely due to higher margins and a lower effective tax rate. The year-over-year change in effective tax rate positively impacted net income by $6.8 million, or $0.30 per diluted share.EBITDA(2) was $53.0 million and Adjusted EBITDA(2) was $53.1 million, up 18% and 11% respectively, year-over-year.Global sales volume was down 1%
10/30/24 7:00:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary
Stepan to Announce Third Quarter 2024 Results on October 30, 2024
NORTHBROOK, Ill., Oct. 9, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its third quarter 2024 earnings results on Wednesday, October 30, 2024 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Scott R. Behrens, President and Chief Executive Officer, and Luis E.
10/9/24 7:00:00 AM ET
$SCL
Package Goods/Cosmetics
Consumer Discretionary

Stepan Q1 2024 Adj EPS $0.64 Beats $0.35 Estimate, Sales $551.418M Miss $575.825M Estimate

Chat with this insight

Recent Analyst Ratings for $SCL

$SCL Press Releases

Fastest customizable press release news feed in the world

Stepan Increases Quarterly Cash Dividend, Marking the 57th Consecutive Year of Increases

Stepan Reports Third Quarter 2024 Results

Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

$SCL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Stepan F Quinn Jr gifted 2,500 shares (SEC Form 4)

SEC Form 4 filed by EVP, Supply Chain Haire Robert Joseph

SEC Form 4 filed by President & CEO Rojo Luis

$SCL Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Stepan Company upgraded by CL King with a new price target

RBC Capital reiterated coverage on Shawcor with a new price target

RBC Capital reiterated coverage on Shawcor with a new price target

$SCL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

VP GC & Secretary Kabbes David bought $75,388 worth of shares (1,056 units at $71.39) (SEC Form 4)

$SCL Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Stepan Company

SEC Form SC 13G/A filed by Stepan Company (Amendment)

SEC Form SC 13G/A filed by Stepan Company (Amendment)

$SCL SEC Filings

SEC Form 10-Q filed by Stepan Company

Stepan Company filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

Stepan Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

$SCL Leadership Updates

Live Leadership Updates

Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

Stepan Company Announces Appointment of New Director

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

$SCL Market Insights

Live Market Insights

Stepan Expects To Deliver Full Year Adjusted EBITDA Growth And Positive Free Cash Flow

Stepan Says On Track To Deliver Its $50M Cost Out Goal For 2024 And Recognized $18M In Pre-tax Savings In Q1